{
  "report_rows": [
    {
      "kpi": "Operating EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$2.36 vs. cons $2.249",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Operating EBITDA (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$2.33B vs. cons $2.223B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Total Revenue (Q2 2026)",
      "prediction": "IN-LINE",
      "answer": "pred ~$6.65B vs. cons $6.589B",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY 2026 Operating EPS (FY 2026)",
      "prediction": "LOWER",
      "answer": "guide ~$3.575 midpoint vs. cons $3.781",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY 2026 Operating EBITDA (FY 2026)",
      "prediction": "LOWER",
      "answer": "guide ~$4.1B midpoint vs. cons $4.203B",
      "confidence": "HIGH"
    },
    {
      "kpi": "Dis-synergy update (qualitative)",
      "prediction": "BETTER",
      "answer": "formal number ~$60-75M net vs. $100M initial estimate",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "CP Pricing tone (qualitative)",
      "prediction": "UNCHANGED",
      "answer": "low single-digit negative maintained; cautious H2 optimism",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -2.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -3.5,
  "day5_path": "FADE",
  "day5_rationale": "FADE \u2014 FY estimate revisions pull toward guide midpoint; all three comparable C-quarters showed negative 5d residuals averaging -3.0%",
  "day5_confidence": "MEDIUM"
}